Fatal septic embolism due to Staphylococcus lugdunensis-induced bacteremia.


Journal

General thoracic and cardiovascular surgery
ISSN: 1863-6713
Titre abrégé: Gen Thorac Cardiovasc Surg
Pays: Japan
ID NLM: 101303952

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 07 04 2019
accepted: 20 12 2020
pubmed: 5 1 2021
medline: 21 5 2021
entrez: 4 1 2021
Statut: ppublish

Résumé

Staphylococcus lugdunensis infective endocarditis (IE) is very rare in children. A female neonote presented with fever on the 29th postoperative day after undergoing a modified Norwood procedure (right ventricular-pulmonary artery [RV-PA] conduit). Blood cultures were positive for S. lugdunensis. Echocardiography did not demonstrate vegetation. Therefore, we made a diagnosis of catheter-related bacteremia instead of IE. Cultures were negative 3 days after treatment initiation with intravenous vancomycin. One month after discharge, she developed acute hypoxia and could not be revived because of obstruction of RV-PA conduit with large vegetation. Even in S. lugdunensis bacteremia without IE, surgical treatment should be considered early.

Identifiants

pubmed: 33394239
doi: 10.1007/s11748-020-01579-w
pii: 10.1007/s11748-020-01579-w
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

993-995

Références

Niwa K, Nakazawa M, Tateno S, Yoshinaga M, Terai M. Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart. 2005;91:795–800.
doi: 10.1136/hrt.2004.043323
Li W, Somerville J. Infective endocarditis in the grown-up congenital (GUCH) population. Eur Heart J. 1998;19:166–73.
doi: 10.1053/euhj.1997.0821
Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr. 1993;122:847–53.
doi: 10.1016/S0022-3476(09)90006-3
Anguera I, Del Río A, Miró JM, Matínez-Lacasa X, Marco F, et al. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart. 2005;91:e10.
doi: 10.1136/hrt.2004.040659
Liu PY, Huang YF, Tang CW, Chen YY, Hsieh KS, et al. Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors. J Microbiol Immunol Infect. 2010;43:478–84.
doi: 10.1016/S1684-1182(10)60074-6
Guillaume MP, Dubos F, Godart F. Staphylococcus lugdunensis endocarditis in children. Cardiol Young. 2017;27:784–7.
doi: 10.1017/S1047951116001657
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96:200–9.
doi: 10.1016/0002-9343(94)90143-0
Hirose K, Ikai A, Nagato H, Murata M, Imai K, Kanno K, et al. Pediatric Case of Staphylococcus lugdunensis-Induced Infective Endocarditis at Bovine Jugular Vein. Ann Thorac Surg. 2019;108:e185–7.
doi: 10.1016/j.athoracsur.2019.01.028

Auteurs

Motonori Ishidou (M)

Department of Cardiovascular Surgery, Mt. Fuji Shizuoka Children's Hospital, Urushiyama 860, Aoi-ku, Shizuoka city, Shizuoka, 420-8660, Japan. i5180835@yahoo.co.jp.

Kazuyoshi Kanno (K)

Department of Cardiovascular Surgery, Mt. Fuji Shizuoka Children's Hospital, Urushiyama 860, Aoi-ku, Shizuoka city, Shizuoka, 420-8660, Japan.

Masaya Murata (M)

Department of Cardiovascular Surgery, Mt. Fuji Shizuoka Children's Hospital, Urushiyama 860, Aoi-ku, Shizuoka city, Shizuoka, 420-8660, Japan.

Keiichi Hirose (K)

Department of Cardiovascular Surgery, Mt. Fuji Shizuoka Children's Hospital, Urushiyama 860, Aoi-ku, Shizuoka city, Shizuoka, 420-8660, Japan.

Akio Ikai (A)

Department of Cardiovascular Surgery, Mt. Fuji Shizuoka Children's Hospital, Urushiyama 860, Aoi-ku, Shizuoka city, Shizuoka, 420-8660, Japan.

Kisaburo Sakamoto (K)

Department of Cardiovascular Surgery, Mt. Fuji Shizuoka Children's Hospital, Urushiyama 860, Aoi-ku, Shizuoka city, Shizuoka, 420-8660, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH